USDM’s Guide to 21 CFR Part 11 Learn about 21 CFR Part 11, the FDA regulation ensuring the security, traceability, and compliance of electronic records and eSignatures in life sciences. David Blewitt - April 14, 2024 Blogs Biotech, CMO, CRO, Medical Device, Pharma Regulatory
Top 10 Considerations for Implementing a GxP Content Management System Discover the top 10 considerations for implementing a GxP-compliant content management system to enhance compliance, efficiency, and data management. Hovsep Kirikian - April 5, 2024 Blogs Biotech, CMO, CRO, Medical Device, Pharma Information Technology
2024 Trends in Life Sciences Life sciences organizations are eager to make use of their vast amounts of data. Explore five trends that are fueling their efforts. Various Authors - March 8, 2024 White Papers Biotech, CMO, CRO, Medical Device, Pharma Information Technology, Quality Assurance
Lessons Learned in the On-Going RPA Journey Blog article topic: Lessons Learned in the On-Going RPA Journey. Ryan McDonald - February 22, 2024 Blogs Biotech, CMO, CRO, Medical Device, Pharma Information Technology
USDM Life Sciences at the American Biomanufacturing Summit We’re excited to see you at the American Biomanufacturing Summit and to hear industry experts Ryan McDonald - February 8, 2024 News & Events Biotech, CMO, Pharma Information Technology, Quality Assurance, Regulatory
RPA GxP-relevant Use Cases Blog article topic: RPA GxP-relevant Use Cases. Ryan McDonald - January 22, 2024 Blogs Biotech, CMO, CRO, Medical Device, Pharma Information Technology, Regulatory
